HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Induction of apoptosis in human breast adenocarcinoma MCF-7 cells by pterocarnin A from the bark of Pterocarya stenoptera via the Fas-mediated pathway.

Abstract
Pterocarnin A, isolated from the bark of Pterocarya stenoptera (Juylandaceae), was investigated for its antiproliferative activity in human breast adenocarcinoma MCF-7 cells. To identify the anticancer mechanism of pterocarnin A, we assayed its effects on apoptosis, cell cycle distribution, and levels of p53, p21/WAF1, Fas/APO-1 receptor and Fas ligand. The results showed that pterocarnin A induced apoptosis of MCF-7 cells without mediation of p53 and p21/WAF1. We suggest that the Fas/Fas ligand apoptotic system is the main pathway of pterocarnin A-mediated apoptosis of MCF-7 cells. Our study reports here for the first time that the activity of the Fas/Fas ligand apoptotic system may participate in the antiproliferative activity of pterocarnin A in MCF-7 cells.
AuthorsPo-Lin Kuo, Ya-Ling Hsu, Shu-Chiao Sung, Wen-Chiu Ni, Ta-Chen Lin, Chun-Ching Lin
JournalAnti-cancer drugs (Anticancer Drugs) Vol. 18 Issue 5 Pg. 555-62 (Jun 2007) ISSN: 0959-4973 [Print] England
PMID17414624 (Publication Type: Journal Article)
Chemical References
  • Antineoplastic Agents, Phytogenic
  • Fas Ligand Protein
  • Glycosides
  • pterocarnin A
  • Gallic Acid
  • Caspase 8
  • Oncogene Protein p21(ras)
Topics
  • Adenocarcinoma (drug therapy, pathology)
  • Antineoplastic Agents, Phytogenic (pharmacology)
  • Apoptosis (drug effects)
  • Blotting, Western
  • Breast Neoplasms (drug therapy, pathology)
  • Caspase 8 (metabolism)
  • Cell Cycle (drug effects)
  • Cell Line, Tumor
  • Cell Proliferation (drug effects)
  • Enzyme-Linked Immunosorbent Assay
  • Fas Ligand Protein (physiology)
  • Gallic Acid (analogs & derivatives, pharmacology)
  • Genes, p53 (genetics)
  • Glycosides (pharmacology)
  • Humans
  • Juglandaceae (chemistry)
  • Oncogene Protein p21(ras) (genetics)
  • Plant Bark (chemistry)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: